ADVIA CENTAUR XP FOLATE (FOL) ASSAY N/A 06891541

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2014-01-09 for ADVIA CENTAUR XP FOLATE (FOL) ASSAY N/A 06891541 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[4047549] Customer observed an increase in the patient running mean for advia centaur xp folate when using reagent lot 071223 when compared to previous reagent lots. There are no known reports of patient treatment being altered or prescribed or adverse health consequences due to the increased advia centaur xp folate results.
Patient Sequence No: 1, Text Type: D, B5


[11370102] The cause for the observed increase in the patient running mean for advia centaur xp folate when using reagent lot 071223 when compared to previous reagent lots is unknown and is currently under investigation. Siemens has requested additional representative patient data. No conclusion can be drawn at this time.
Patient Sequence No: 1, Text Type: N, H10


[34902958] Siemens filed the initial mdr 1219913-2014-00007 on 01/09/2014 for an increase in the patient running mean and qc for advia centaur xp folate whole blood when using reagent lot 071223 compared to previously used reagent lots. 04/09/2014 - additional information: customer's running patient mean summarized data: (b)(6). Based upon additional information and investigation, on march 25, 2014, siemens issued an urgent medical device recall (108180053) to its customers in the united states and an urgent field safety notice (10818055) to its customers outside of the united states, related to the advia centaur folate assay. Siemens has determined that the advia centaur systems folate assay, kit lots ending in 222, 224, 225, 226 and/or 227, meets the published claims in the ifu for normal whole blood cell folate. The whole blood cell folate results for lots ending in 219 may show a negative bias of up to 41. 2% relative to new lots 224, 225, 226, and 227. This negative bias may result in a patient receiving folate supplementation; however, this supplementation does not constitute a risk to health.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2014-00007
MDR Report Key3566505
Report Source05,06
Date Received2014-01-09
Date of Report2013-12-12
Date of Event2013-12-05
Date Mfgr Received2014-03-18
Date Added to Maude2014-04-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. STEPHEN PERRY
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604163
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionRC
Previous Use Code3
Removal Correction Number1219913-03/25/2014-001-R
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP FOLATE (FOL) ASSAY
Generic NameFOLATE IMMUNOASSAY, PRODUCT CODE:
Product CodeCGN
Date Received2014-01-09
Model NumberN/A
Catalog Number06891541
Lot Number071223
ID NumberN/A
Device Expiration Date2014-05-12
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2014-01-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.